As of 2026-10-05, the Relative Valuation of Angion Biomedica Corp (ANGN) is (19.33) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.00 USD, the upside of Angion Biomedica Corp based on Relative Valuation is -2033.0%.
The range of the Relative Valuation is (17.01) - (25.54) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.6x - 19.8x | 12.4x |
| Forward P/E multiples | 13.2x - 21.1x | 17.6x |
| Fair Price | (17.01) - (25.54) | (19.33) |
| Upside | -1801.1% - -2654.2% | -2033.0% |
| Date | P/E |